Cargando…
Acute myocardial infarction, associated with the use of a synthetic adamantyl-cannabinoid: a case report
BACKGROUND: “Legal highs” are novel psychoactive substances that have evaded statutory control. Synthetic cannabinoid compounds with adamantane moieties have recently been identified, which have high potency at target receptors and are undetectable on conventional toxicology testing. However, little...
Autores principales: | McIlroy, Graham, Ford, Loretta, Khan, Jawad M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715335/ https://www.ncbi.nlm.nih.gov/pubmed/26772803 http://dx.doi.org/10.1186/s40360-016-0045-1 |
Ejemplares similares
-
Phase I In Vitro Metabolic Profiling of the Synthetic Cannabinoid Receptor Agonists CUMYL-THPINACA and ADAMANTYL-THPINACA
por: Monti, Manuela Carla, et al.
Publicado: (2021) -
Synthetic Cannabinoids and ST-Elevated Myocardial Infarction: A Case Report and Literature Review
por: Iftikhar, Hassaan, et al.
Publicado: (2023) -
Acute Rhabdomyolysis Following Synthetic Cannabinoid Ingestion
por: Adedinsewo, Demilade A., et al.
Publicado: (2016) -
“Spice” (Synthetic Marijuana) Induced Acute Myocardial Infarction: A Case Series
por: Ul Haq, E., et al.
Publicado: (2017) -
Enantioseparation of P-Stereogenic 1-Adamantyl Arylthiophosphonates and Their Stereospecific Transformation to 1-Adamantyl Aryl-H-phosphinates
por: Varga, Bence, et al.
Publicado: (2023)